FDA Inspection 1049715 — Vaughn, Silverberg and Associates, LLP

Vaughn, Silverberg and Associates, LLP — FEI 3003724356

The FDA completed an inspection of Vaughn, Silverberg and Associates, LLP on March 29, 2018 in Austin, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 29, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Austin, TX (United States)